Dr Kirsty McHugh is Programme Lead for Antibody Discovery and Characterisation within the Draper Malaria Research Group at the University of Oxford, and a Fellow in Biochemistry at Pembroke College.
Her research focuses on understanding how antibodies recognise and inhibit malaria parasites, and using these insights to develop more effective vaccines and antibody-based therapeutics. She leads a portfolio of research programmes within the wider Draper Group, including projects for which she is Principal Investigator, spanning monoclonal antibody discovery, engineering, functional characterisation, and antibody-guided vaccine design. Her research includes Gates Foundation-funded programmes investigating protective antibody responses and developing next-generation blood-stage malaria vaccines targeting AMA1.
A major focus of her work is the development and application of advanced technologies for high-throughput antibody discovery and characterisation, including single-cell B-cell sequencing and high-throughput surface plasmon resonance (HT-SPR). She leads the Group's HT-SPR facility, which supports a growing range of research programmes and collaborations within Oxford and with external academic and industry partners. By integrating antibody repertoire analysis, epitope mapping, biophysical measurements, and functional assays, her research seeks to understand the molecular determinants of antibody potency and protection and apply these insights to improved vaccine and therapeutic design.